Opinion

Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination

Invivyd authors evaluated early side effects of prior low-dose investigational monoclonal antibody adintrevimab from the EVADE study, demonstrating minimal tolerability issuesResults allow for ...

Europe—not US—first to authorize Moderna’s combo mRNA flu-COVID vaccine

Moderna’s mRNA-based combination vaccine against both flu and COVID-19 has gotten the green light in Europe—but it continues to be shelved in the US, where it was developed. This week, the European ...
Medical Xpress

Conflicting advice on COVID shots likely to ding already low vaccine rates, experts warn

More than three-quarters of American adults didn't get a COVID shot last season, a figure that health care experts warn could rise this year amid new U.S. government recommendations. The COVID vaccine ...

New clinical trial method speeds up Shionogi vaccine rollout

Shionogi & Co. looks set to put its COVID-19 vaccine into practical use by the end of March 2022 following a government ...
The Independent

FDA commissioner defends agency for taking its time to review coronavirus vaccine

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...